• the rare instances where maternal antimicrobial therapy indicates a caution for breastfeeding, and
• when to continue breastfeeding as a mother, or her infant, receives a routine recommended immuniza tion.
Maternal infectious diseases and breastfeeding
Almost immediately after birth, infants acquire intesti nal flora that are seeded from their mother's microbio ta. An infant's microbiotal flora vary by mode of deliv ery [3] and are further shaped by genetics, environment, and the mode of feeding. [4] Breast milk influences the infant's intestinal microbiota by contributing maternal skin organisms as well as components that nurture some microbes and offer protection from others . [4] [5] Breast milk also directly influences development of the infant's immune system, [4] [5] and breastfeeding impacts health in many positive ways. [2] While breast milk can be a source of maternally de rived commensal and pathogenic microorganisms, [5] there are very few maternal infectious diseases for which the cessation or interruption of breastfeeding is indicated. [2] [4] [5] When a nursing mother presents with symptoms of an infectious disease, she has already exposed her infant to the pathogen. Cessation of breastfeeding does not prevent exposure, and may instead decrease the infant's protection that comes through specific mater nal antibodies and other protective factors found in hu man milk. Therefore, common maternal bacterial, fun gal and viral infections in which the mother's health is not compromised are not contraindications to breast feeding (Table 1) . Maternal bacterial infections are rarely complicated by transmission to the infant through breastfeeding, with the possible exception of brucellosis. [6] [7] Mothers with mastitis or breast abscesses should be encouraged to continue breastfeeding. [2] [5][8] [9] In instances of breast abscess where pain interferes with breastfeeding, the infant can continue to breastfeed on the nonabscessed breast. [5] Similarly, maternal tuberculosis (TB) is com patible with breastfeeding, provided the mother is not contagious or she has received two weeks of appropri ate TB treatment. [2] [5] Because transmission of TB is airborne and the infection cannot be transferred in hu man milk, continuing to breastfeed while on TB therapy is not a problem. TB medications appear to be safe to use while breastfeeding. [10] - [12] The breastfed neonates of women on isoniazid therapy do not need pyridoxine supplementation, unless they are receiving isoniazid themselves. [11] If mother and infant are both taking iso niazid, there may be concerns about possible exces sive drug concentration in the infant. Consultation with an expert is indicated.
With parasitic infections such as malaria, breastfeed ing should be continued provided the mother's clinical condition allows for it. While the antimalarials chloro quine, hydroxychloroquine and quinine are found in variable quantities in breast milk, all three are regarded as compatible with breastfeeding unless the infant has glucose-6-phosphate dehydrogenase (G6PD) deficien cy, in which case withdrawal of quinine is advised. [12] Similarly, primaquine should not be used unless both mother and infant have normal G6PD levels. Precau tions to minimize insect-borne infections should be en couraged. Insect repellents help to reduce mosquito bites, which may transmit malaria or viruses such as West Nile. There are no reported adverse events fol lowing use of repellents containing diethyltoluamide or icaridin/picaridin in breastfeeding mothers. [13] While maternal fungal infections such as candidal vaginitis can lead to infant colonization, this is not a contraindication to breastfeeding, nor is maternal treat ment with topical or systemic antifungal agents such as fluconazole. [12] For most maternal viral infections, ongoing breastfeed ing is recommended with few exceptions (Table 1) . [2] [14] [15] In cases of maternal HIV infection, breastfeeding is not recommended in resource-rich settings such as Canada, where a safe and culturally accepted replace ment is available, [2] because HIV transmission from mother to infant is well documented. Emotional support for the mother who cannot breastfeed may be re quired. In some instances, financial support for pur chasing formula may also be necessary. In resourcelimited regions of the world, and based on evaluation of current best evidence, the WHO recommends that HIV-positive mothers or their HIV-exposed infants take antiretroviral drugs throughout the period of breast feeding and continue to breastfeed until the infant is 12 months old. The infant can reap the benefits of breast feeding with minimal risk of becoming infected with HIV. [16] [17] Breastfeeding is also not advised for mothers with hu man T-lymphotropic virus type 1 or 2 infection. [2] [ 15] In mothers with latent cytomegalovirus (CMV) infection, the virus reactivates in breast milk during the postpar tum period and can be transmitted to the infant with breastfeeding . However, transmittal does not pose a risk to the term infant because serious disease is pre vented by placentally transferred maternal antibody. [2] Even in preterm infants, the value of breastfeeding ap pears to outweigh the potential risks of severe disease from breast milk-acquired CMV infection in the neona tal period. A definitive association with delayed devel opment or sensorineural hearing loss has not been proven. [2] [18] Thus, breast feeding is recommended with both maternal latent and active CMV infection.
Maternal antimicrobial therapy and breastfeeding
There are very few instances in which maternal thera py with commonly used antimicrobial agents precludes continuation of breastfeeding. [ 
Maternal immunization and breastfeeding
Breastfeeding is not a contraindication to the adminis tration of routine recommended vaccines to the infant or the mother. Breastfeeding during immunization can help mitigate the infant's pain and should be encour aged. [23] 
